CCCX SEC filings, in plain English
Everything Churchill Capital Corp X has filed with the SEC that we hold — 40 filings, newest first, 10 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: 8-K/A of Infleqtion, Inc. Item 2.02 (results of operations and financial condition): a corrected version of the earnings release is furnished as Exhibit 99.1, which the report says updates and supersedes the earnings release furnished with the Original Form 8-K with respect to the information presented therein; apart from Item 2.02, all other information in the Original Form 8-K and Earnings Release remains unchanged. The information is furnished, not filed, for Section 18 purposes. Exhibit 99.1 is a press release dated August 17, 2026; Exhibit 104 is the cover page Inline XBRL. Why it matters: An earnings release was wrong enough to be reissued under a new accession. The amendment never says which figures were corrected: the substance is entirely in Exhibit 99.1, which is not part of this document, so the record shows that a correction happened and not what it was.
What changed: The 10-Q for the quarter ended June 30, 2026 filed under Commission file number 001-42646 is that of Infleqtion, Inc. (NYSE: INFQ), with 225,357,052 shares of common stock outstanding as of August 14, 2026 and warrants exercisable at $11.50. The filing states that the merger was consummated on February 13, 2026, pursuant to which Churchill Capital Corp X acquired ColdQuanta, Inc. (d/b/a Infleqtion) and redomesticated and renamed itself Infleqtion, Inc., a Delaware corporation. Why it matters: This is the successor's second quarterly report after the de-SPAC and it confirms the February 13, 2026 closing date and a 225 million share count against the SPAC's original public float. The company states material weaknesses in internal control exist and remain to be remediated. The condensed consolidated financial statements are not in the portion read here.
combination deadlinenothing moved · 1 with no prior record of ours
- Combination deadline
- 2037-08-31 · unchanged
The clause “68,000 square feet and extends the lease expiration date from March 31, 2030 to August 31, 2037. In June 2026, the Company executed an amendment to its operating lease for its Oxford, U.K. facility. The amendment increases the leased”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Infleqtion (post-CCCX merger, now NYSE: INFQ) reported Q2 2026 revenue of $12.6M (+116% YoY) and raised full-year 2026 revenue guidance to ~$43M, with $582M in cash and securities and no debt as of June 30, 2026. The company received a U.S. Commerce Department LOI for up to $100M in proposed funding and remains on track for 30 logical qubits in 2026. Why it matters: This is the first full quarterly report since the CCCX merger closed, showing the de-SPAC target executing commercially with strong revenue growth and a substantial cash runway from the $528M in net Business Combination proceeds. GAAP operating loss widened to $30.6M from $10.1M, reflecting heavy investment in scaling, with 224.7M shares outstanding versus 17.4M pre-merger.
What changed: Prospectus Supplement No. 4 (dated July 14, 2026) to the April 9, 2026 resale prospectus on Form S-1 (No. 333-294802) of the post-combination company, filed solely to update selling-securityholder information after entities affiliated with Global Frontier distributed 23,251,796 shares in kind to limited partners on July 10, 2026 (largest recipients: S G Foundation 11,573,878 shares, FW Global Frontiers Investors LP 2,418,323, LAD Trust 2,085,798, Capital Partnership (CMB) LP 1,943,807, W. Grant Dollens 1,994,448, William E. Greener 1,871,018). The prospectus covers up to 121,829,432 resale shares — 12,654,760 PIPE shares from September 8, 2025 subscription agreements, 10,350,000 Sponsor founder shares (including 1,500,000 unvested at Closing that re-vest on the Triggering Event), 300,000 CCX private placement shares and 98,449,672 shares issued to former ColdQuanta (Infleqtion) holders — plus 10,425,000 warrant shares. Common stock and public warrants trade on NYSE as INFQ and INFQ WS; on July 14, 2026 the stock last traded at $10.45 and warrants at $5.35. Why it matters: Confirms the Churchill Capital Corp X / Infleqtion combination has closed and the successor trades on NYSE as INFQ. The registered resale overhang is 121.8 million shares against a stock at $10.45, and Global Frontier's in-kind distribution puts 23.25 million previously locked shares into the hands of individual LPs who face no coordinated sale restriction.
What changed: Prospectus Supplement No. 3 (dated June 5, 2026) to the April 9, 2026 resale prospectus on Form S-1 (No. 333-294802), filed solely to update selling-securityholder information for the June 2, 2026 in-kind distribution of 3,825,935 shares by entities affiliated with Maverick Capital to its limited partners; recipients include Matthew Kinsella (7,814,538 shares registered), Cohasset VC Ltd (1,386,242), Illiquid Markets 1888 Fund LLC (331,507), Singer-Kapp Revocable Trust (324,320) and Premera Blue Cross (215,053). The underlying prospectus covers up to 121,829,432 resale shares plus 10,425,000 warrant shares. Common stock and public warrants trade on NYSE as INFQ and INFQ WS; on June 4, 2026 the last reported prices were $16.95 per share and $8.88 per warrant. Why it matters: Shows the post-deSPAC Infleqtion stock at $16.95 in early June 2026, well above the $10 SPAC reference, while sponsor and legacy-holder shares continue to be distributed out of funds to individual LPs who can sell into the registered 121.8 million share overhang.
What changed: First post-deSPAC 10-Q filed under the Churchill Capital Corp X CIK but as Infleqtion, Inc. (NYSE: INFQ; warrants INFQ WS) for the quarter ended March 31, 2026. The filing confirms the merger consummated February 13, 2026, in which Churchill Capital Corp X acquired ColdQuanta, Inc. (d/b/a Infleqtion), redomesticated to Delaware and renamed itself Infleqtion, Inc. As of May 12, 2026 there were 218,196,891 shares of common stock outstanding. Risk language flags an operating-loss history and the need for substantial additional capital. Why it matters: Confirms CCCX is no longer a SPAC — it is an operating quantum-computing company reporting as Infleqtion with 218.2 million shares outstanding.
What changed vs 2025-11-12deadline 2027-05-15 → 2037-08-31combination deadline, trust account, redeemable shares1 moved · 2 with no prior record of ours
- Combination deadline
- 2027-05-152037-08-31
- Trust account
- $419.6Mnot matched in this filing
- Redeemable shares
- 41.4Mnot matched in this filing
SpacBrain reads this as 3761 days later than the previous record.
The clause “68,000 square feet and extends the lease expiration date from March 31, 2030 to August 31, 2037. Incremental lease payments associated with the amendment total approximately $25 million over the extended term. 32 Table of Contents”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Prospectus Supplement No. 2 (dated May 15, 2026) to the April 9, 2026 resale prospectus, attaching Infleqtion, Inc.'s Form 10-Q for the quarter ended March 31, 2026. The 10-Q confirms the merger was consummated on February 13, 2026, under which Churchill Capital Corp X acquired ColdQuanta, Inc. (d/b/a Infleqtion), redomesticated and renamed itself Infleqtion, Inc., a Delaware corporation, Commission File No. 001-42646, headquartered at 1315 West Century Drive, Suite 150, Louisville, CO. As of May 12, 2026 there were 218,196,891 shares of common stock outstanding. Common stock and warrants (exercisable at $11.50) trade on NYSE as INFQ and INFQ WS; on May 14, 2026 the stock last traded at $13.97 and the warrants at $7.33. Why it matters: Pins the deSPAC closing date at February 13, 2026 and the post-close share count at 218.2 million, the denominator for any per-share analysis of the former Churchill Capital Corp X trust. The stock traded at $13.97 in mid-May 2026 against the $10.00 SPAC reference price.
What changed: The 8-K was filed by INFLEQTION, INC. (NYSE: INFQ, formerly ColdQuanta, Inc.), the post-closing successor to Churchill Capital Corp X, reporting that on May 8, 2026 the board appointed Nicholas Johnson, 38, Partner of Archimedes Advisor Group and Managing Director of M. Klein & Company, as a Class III director with a term expiring at the 2029 annual meeting. The appointment was made under Section 8.09 of the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, AH Merger Sub I, AH Merger Sub II and ColdQuanta (d/b/a Infleqtion), which gave Churchill Sponsor X LLC the right to designate one Class III director. Johnson was determined not independent under NYSE standards because of the September 2025 Advisory Agreement under which M. Klein & Company receives $250,000 per quarter for two years post-closing, plus 5% of underwriting fees on capital markets financings and 3% of gross proceeds on strategic investments where retained. Why it matters: Confirms the Churchill Capital Corp X / Infleqtion deSPAC has closed and now trades as INFQ on the NYSE, and quantifies the ongoing sponsor-affiliate drag: $1 million per year of advisory fees to M. Klein & Company plus success fees on future financings.
What changed: Infleqtion (formerly Churchill Capital Corp X) reported Q1 2026 results: revenue of $9.461 million, up 14% year over year and entirely organic; gross profit $1.991 million (down from $3.377 million); GAAP loss from operations of $33.575 million versus $6.950 million a year earlier; net loss $30.263 million ($0.26 per share on 118.2 million weighted average shares); non-GAAP operating loss $13.2 million. Cash, equivalents and available-for-sale securities were $569 million at March 31, 2026 ($84.674 million cash plus $358.866 million current and $125.117 million non-current AFS securities) against total assets of $612.611 million; net cash used in operations was $19.2 million. 2026 revenue guidance was raised to at least $40 million. 216,471,927 shares were outstanding at March 31, 2026 versus 17,449,020 at December 31, 2025. Why it matters: First public quarter for the deSPAC: the $569 million cash pile is real but the operating loss quadrupled year over year and $40 million of 2026 revenue implies a very high multiple; the share count jumped 12x from the merger and preferred conversion.
What changed: Prospectus Supplement No. 1 (May 14, 2026) attaching Infleqtion, Inc.'s Form 8-K reporting that on May 8, 2026 the board appointed Nicholas Johnson, 38, Partner of Archimedes Advisor Group and Managing Director of M. Klein & Company, as a Class III director with a term expiring at the 2029 annual meeting. The appointment was made under Section 8.09 of the Merger Agreement, which gave Churchill Sponsor X LLC the right to designate one Class III director. The board determined Johnson is not independent under NYSE standards because M. Klein & Company is the Advisor under a September 2025 advisory agreement paying $250,000 per quarter for two years from Closing, plus 5% of total underwriting fees on capital markets financings and 3% of gross proceeds on strategic investments if the Company retains the Advisor; Johnson receives no director compensation while that agreement is in effect. On May 13, 2026 INFQ last traded at $13.29 and INFQ WS at $6.61. Why it matters: Quantifies the sponsor's continuing post-close economics: $1 million a year in advisory fees to a Michael Klein affiliate for two years plus success-based transaction fees, alongside a board seat held by a designee the company itself deems non-independent.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.